Bryophytes of Uganda : 1., BBS Tropical Bryology Group expeditions, 1996-1998 ; introduction and collecting sites

The British Bryological Society Tropical Bryology Group (TBG) undertook three expeditions to Uganda, in Jan-Feb 1996, Jan-Feb 1997 and June-Jul 1998. Collections were made from 134 sites, mainly from national parks and forest reserves in western and southern Uganda

British Bryological Society expedition to Mulanje Mountain, Malawi : 13., new and other unpublished records

Further results are provided of the 1991 British Bryological Society Expedition to Mulanje Mt., Malawi including 168 taxa of bryophyte, comprising 72 taxa of liverwort (38 new to Malawi) and 96 taxa of mosses (45 new to Malawi)

Bryophytes of Uganda : 2., new and interesting records

51 hepatics and 46 mosses are reported new to Uganda, including one moss new to Africa, one hepatic and two mosses new to mainland Africa, and 2 hepatics that are otherwise known only from their type collection

Construction of a transformer DGA health index based on DGA screening processes

An automated transformer dissolved gas analysis evaluation system based on the recently released IEEE Standard C57.104-2019 for mineral oil-immersed transformers is implemented and its outputs demonstrated. The system includes diagnostic capabilities using the Duval Triangles 1-4-5 and Rogers Ratio method. In addition, a Health Index derived from the above Standards is proposed as a compact, yet informative metric for tracking transformer health. Finally, some of the challenges in developing such an implementation are highlighted

A New Shear Estimator for Weak Lensing Observations

We present a new shear estimator for weak lensing observations which properly accounts for the effects of a realistic point spread function (PSF). Images of faint galaxies are subject to gravitational shearing followed by smearing with the instrumental and/or atmospheric PSF. We construct a `finite resolution shear operator' which when applied to an observed image has the same effect as a gravitational shear applied prior to smearing. This operator allows one to calibrate essentially any shear estimator. We then specialize to the case of weighted second moment shear estimators. We compute the shear polarizability which gives the response of an individual galaxy's polarization to a gravitational shear. We then compute the response of the population of galaxies, and thereby construct an optimal weighting scheme for combining shear estimates from galaxies of various shapes, luminosities and sizes. We define a figure of merit --- an inverse shear variance per unit solid angle --- which characterizes the quality of image data for shear measurement. The new method is tested with simulated image data. We discuss the correction for anisotropy of the PSF and propose a new technique involving measuring shapes from images which have been convolved with a re-circularizing PSF. We draw attention to a hitherto ignored noise related bias and show how this can be analyzed and corrected for. The analysis here draws heavily on the properties of real PSF's and we include as an appendix a brief review, highlighting those aspects which are relevant for weak lensing.Comment: 39 pages, 9 figure

Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for Pleural infection Therapy project

Rationale: Intrapleural therapy with a combination of tissue plasminogen activator (tPA) 10 mg and DNase 5 mg administered twice daily has been shown in randomized and open-label studies to successfully manage over 90% of patients with pleural infection without surgery. Potential bleeding risks associated with intrapleural tPA and its costs remain important concerns. The aim of the ongoing Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) project is to investigate the efficacy and safety of dose de-escalation for intrapleural tPA. The first of several planned studies is presented here. Objectives: To evaluate the efficacy and safety of a reduced starting dose regimen of 5 mg of tPA with 5 mg of DNase administered intrapleurally for pleural infection. Methods: Consecutive patients with pleural infection at four participating centers in Australia, the United Kingdom, and New Zealand were included in this observational, open-label study. Treatment was initiated with tPA 5 mg and DNase 5 mg twice daily. Subsequent dose escalation was permitted at the discretion of the attending physician. Data relating to treatment success, radiological and systemic inflammatory changes (blood C-reactive protein), volume of fluid drained, length of hospital stay, and treatment complications were extracted retrospectively from the medical records. Results: We evaluated 61 patients (41 males; age, 57 ± 16 yr). Most patients (n = 58 [93.4%]) were successfully treated without requiring surgery for pleural infection. Treatment success was corroborated by clearance of pleural opacities visualized by chest radiography (from 42% [interquartile range, 22–58] to 16% [8–31] of hemithorax; P < 0.001), increase in pleural fluid drainage (from 175 ml in the 24 h preceding treatment to 2,025 ml [interquartile range, 1,247–2,984] over 72 h of therapy; P <  0.05) and a reduction in blood C-reactive protein (P < 0.05). Seven patients (11.5%) had dose escalation of tPA to 10 mg. Three patients underwent surgery. Three patients (4.9%) received blood transfusions for gradual pleural blood loss; none were hemodynamically compromised. Pain requiring escalation of analgesia affected 36% of patients; none required cessation of therapy. Conclusions: These pilot data suggest that a starting dose of 5 mg of tPA administered intrapleurally twice daily in combination with 5 mg of DNase for the treatment of pl

Impaired pre-competition wellbeing measures can negatively impact running performance in developmental youth female soccer players

This study aimed to determine the association between pre-competition perceived player wellbeing measures and subsequent relative and peak running performance of developmental youth female soccer players (n = 15, age: 16 ± 1 years). Total distance (TD), high-speed (&gt; 3.5 m/s) (HSRD) and very high-speed (&gt; 5.3 m/s) running (VHSRD) were expressed using 1-, 2- and 5-minute epochs and relative (per minute) calculations. Fatigue, sleep quality, upper and lower-body muscle soreness, stress, and mood wellbeing measures were collected via a self-reported questionnaire (1-5 Likert scale). Menstrual cycle phase was collected via a calendar-based countback method. Results demonstrated that reductions in stress was associated with decreased relative and peak TD in all epochs ( p = 0.008-0.040), relative and peak HSRD ( p = 0.006-0.039) in 2- and 5-minute epochs as well as VHSRD in 2-minute epochs ( p = 0.026). For example, a one-point reduction of 'normal' to 'relaxed' is associated with a decrease of 7 m/min in peak TD for 1-minute epochs. One-point increase in fatigue (e.g., 'normal' to 'more tired than normal') displayed a decrease of 7 m/min peak TD for 2-minute ( p = 0.048) and 9 m/min for 5-minute ( p = 0.007) rolling epochs. Likewise, one-point increase in lower-body muscle-soreness (e.g., 'normal' to 'increase in soreness/tightness') was associated with a reduction of 6 m/min peak VHSRD for 1-minute epochs ( p = 0.034). Results suggest that perceived player wellbeing can influence running performance. However, the magnitude of the change in player wellbeing should be considered in a practical sense. </p